ONCAlert | 2018 ASCO Annual Meeting

New Data for EGFR Inhibitors for Lung Cancer

Suresh S. Ramalingam, MD
Published Online: 7:34 PM, Sat May 31, 2014
Suresh S. Ramalingam, MD, a professor of medical oncology at the Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses data presented at the 2014 ASCO Annual Meeting examining EGFR inhibitors for lung cancer.

<<< Back to the ASCO 2014 conference page

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.